Meaning-Centered Pain Coping Skills Training
1 other identifier
interventional
60
1 country
1
Brief Summary
This study is a randomized clinical trial of a psychosocial pain management intervention called, Meaning-Centered Pain Coping Skills Training (MCPC). Patients with advanced solid tumor cancer and at least moderate pain will be randomized to MCPC or a standard care control condition. Patient-reported outcomes will be assessed at baseline and 5- and 10-week follow-ups. The first aim of this study is to assess the feasibility of conducting a randomized clinical trial to test MCPC. The second aim is to characterize MCPC's effects on patient-reported outcomes of pain severity, pain interference, meaning in life, self-efficacy for pain management, and psychological distress. The third aim is to describe participants' experiences of MCPC using semi-structured qualitative interviews. The risk and safety issues in this trial are low and limited to those common to a psychosocial intervention (e.g., loss of confidentiality).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2020
CompletedFirst Posted
Study publicly available on registry
June 16, 2020
CompletedStudy Start
First participant enrolled
February 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 3, 2022
CompletedMay 4, 2022
May 1, 2022
1.1 years
June 11, 2020
May 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility as measured by study accrual
Treatment feasibility will be evidenced by meeting study accrual (N = 60).
Baseline
Feasibility as measured by adherence and assessment completion
Treatment feasibility will be evidenced by at least 75% of participants completing all four intervention sessions as well as the 5-week follow-up assessment.
5-week follow-up (immediately post-intervention)
Feasibility as measured by attrition
Treatment feasibility will be evidenced by no more than 25% attrition by the 5-week follow-up.
5-week follow-up (immediately post-intervention)
Secondary Outcomes (7)
Change in pain severity
Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up
Change in pain interference
Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up
Change in meaning in life
Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up
Change in self-efficacy for pain management
Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up
Change in anxiety
Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up
- +2 more secondary outcomes
Study Arms (2)
Meaning-Centered Pain Coping Skills Training
EXPERIMENTALFour, 45-60 minute, videoconference-delivered sessions focus on training participants in cognitive and behavioral skills (e.g., guided imagery) for managing pain.
Standard Care
NO INTERVENTIONInformation and referrals for free services available through the Duke Cancer Patient Support Program.
Interventions
The goal of this intervention is to help participants manage pain so that they can engage with what gives them a sense of meaning, purpose, and significance in life.
Eligibility Criteria
You may qualify if:
- Stage IV solid tumor cancer diagnosis; or stage III pancreatic or lung cancer diagnosis
- At least moderate pain (worst pain in past week \>/= 4 out of 10) at screening
- Eastern Cooperative Oncology Group (ECOG) performance status \</= 2 at screening
- Ability to speak and read English
You may not qualify if:
- Brain tumor diagnosis
- Significant cognitive impairment
- Untreated serious mental illness that would interfere with engagement in the interventions (e.g., schizophrenia)
- Previous engagement in Pain Coping Skills Training or Meaning-Centered Psychotherapy
- Enrollment in hospice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Icahn School of Medicine at Mount Sinaicollaborator
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27705, United States
Related Publications (1)
Winger JG, Kelleher SA, Ramos K, Check DK, Yu JA, Powell VD, Lerebours R, Olsen MK, Keefe FJ, Steinhauser KE, Porter LS, Breitbart WS, Somers TJ. Meaning-centered pain coping skills training for patients with metastatic cancer: Results of a randomized controlled pilot trial. Psychooncology. 2023 Jul;32(7):1096-1105. doi: 10.1002/pon.6151. Epub 2023 May 12.
PMID: 37173865DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph G Winger, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2020
First Posted
June 16, 2020
Study Start
February 9, 2021
Primary Completion
March 31, 2022
Study Completion
May 3, 2022
Last Updated
May 4, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share